Vir Biotechnology (VIR) Current Taxes (2021 - 2023)

Vir Biotechnology has reported Current Taxes for 3 years, with the latest figure at $15.3 million in Q1 2023.

• Quarterly Current Taxes fell 96.23% year-over-year to $15.3 million in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $15.3 million (down 96.23% YoY) and the FY2022 annual result came in at $15.2 million, up 144.94% from the prior year.
• Current Taxes was little changed at $15.3 million in Q1 2023 per VIR's latest filing, from $15.2 million in the prior quarter.
• Over five years, Current Taxes peaked at $404.4 million in Q1 2022 and troughed at $6.2 million in Q4 2021.
• A 3-year average of $116.1 million and a median of $56.7 million in 2022 frame the typical range for Current Taxes.
• The sharpest annual moves came in 2022 and 2023: Current Taxes jumped 144.94% in 2022, then tumbled 96.23% in 2023.
• Over 3 years, Current Taxes stood at $6.2 million in 2021, then jumped by 144.94% to $15.2 million in 2022, then gained by 0.16% to $15.3 million in 2023.
• According to Business Quant data, Current Taxes over the past three periods registered $15.3 million, $15.2 million, and $98.2 million for Q1 2023, Q4 2022, and Q3 2022 respectively.